nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—BCHE—diaphragm—ovarian cancer	0.0936	0.173	CbGeAlD
Succinylcholine—CHRM3—muscle of abdomen—ovarian cancer	0.0919	0.17	CbGeAlD
Succinylcholine—CHRNG—myometrium—ovarian cancer	0.0522	0.0966	CbGeAlD
Succinylcholine—CHRNE—testis—ovarian cancer	0.0492	0.091	CbGeAlD
Succinylcholine—CHRNG—bone marrow—ovarian cancer	0.0287	0.0532	CbGeAlD
Succinylcholine—CHRNA10—vagina—ovarian cancer	0.0234	0.0432	CbGeAlD
Succinylcholine—CHRNA10—testis—ovarian cancer	0.0208	0.0386	CbGeAlD
Succinylcholine—CHRNB1—uterine cervix—ovarian cancer	0.0208	0.0384	CbGeAlD
Succinylcholine—CHRNA10—lymph node—ovarian cancer	0.0151	0.028	CbGeAlD
Succinylcholine—CHRNB1—female gonad—ovarian cancer	0.0142	0.0262	CbGeAlD
Succinylcholine—CHRNB1—vagina—ovarian cancer	0.0141	0.026	CbGeAlD
Succinylcholine—CHRNB1—testis—ovarian cancer	0.0126	0.0232	CbGeAlD
Succinylcholine—Rhabdomyolysis—Melphalan—ovarian cancer	0.0117	0.0307	CcSEcCtD
Succinylcholine—BCHE—myometrium—ovarian cancer	0.0114	0.021	CbGeAlD
Succinylcholine—Respiratory failure—Topotecan—ovarian cancer	0.0108	0.0283	CcSEcCtD
Succinylcholine—Renal failure acute—Chlorambucil—ovarian cancer	0.00936	0.0245	CcSEcCtD
Succinylcholine—Respiratory failure—Vinorelbine—ovarian cancer	0.00923	0.0242	CcSEcCtD
Succinylcholine—CHRNB1—lymph node—ovarian cancer	0.00911	0.0168	CbGeAlD
Succinylcholine—CHRM1—female reproductive system—ovarian cancer	0.00908	0.0168	CbGeAlD
Succinylcholine—BCHE—uterine cervix—ovarian cancer	0.00885	0.0164	CbGeAlD
Succinylcholine—Renal failure acute—Melphalan—ovarian cancer	0.00816	0.0214	CcSEcCtD
Succinylcholine—CHRM3—female reproductive system—ovarian cancer	0.00813	0.015	CbGeAlD
Succinylcholine—Pulmonary oedema—Vinorelbine—ovarian cancer	0.00807	0.0211	CcSEcCtD
Succinylcholine—BCHE—endometrium—ovarian cancer	0.00801	0.0148	CbGeAlD
Succinylcholine—Anaphylactoid reaction—Topotecan—ovarian cancer	0.00795	0.0208	CcSEcCtD
Succinylcholine—CHRM3—female gonad—ovarian cancer	0.00739	0.0137	CbGeAlD
Succinylcholine—BCHE—uterus—ovarian cancer	0.00738	0.0137	CbGeAlD
Succinylcholine—Cardiac arrest—Topotecan—ovarian cancer	0.00731	0.0192	CcSEcCtD
Succinylcholine—Cardiac arrest—Melphalan—ovarian cancer	0.00716	0.0188	CcSEcCtD
Succinylcholine—BCHE—female reproductive system—ovarian cancer	0.00663	0.0123	CbGeAlD
Succinylcholine—CHRM3—testis—ovarian cancer	0.00656	0.0121	CbGeAlD
Succinylcholine—Body temperature increased—Carboplatin—ovarian cancer	0.00653	0.0171	CcSEcCtD
Succinylcholine—Bronchospasm—Melphalan—ovarian cancer	0.0064	0.0168	CcSEcCtD
Succinylcholine—BCHE—bone marrow—ovarian cancer	0.00626	0.0116	CbGeAlD
Succinylcholine—Respiratory failure—Paclitaxel—ovarian cancer	0.00621	0.0163	CcSEcCtD
Succinylcholine—BCHE—vagina—ovarian cancer	0.006	0.0111	CbGeAlD
Succinylcholine—Bronchospasm—Vinorelbine—ovarian cancer	0.00559	0.0146	CcSEcCtD
Succinylcholine—BCHE—testis—ovarian cancer	0.00535	0.0099	CbGeAlD
Succinylcholine—Hypertonia—Paclitaxel—ovarian cancer	0.00534	0.014	CcSEcCtD
Succinylcholine—Respiratory failure—Docetaxel—ovarian cancer	0.00526	0.0138	CcSEcCtD
Succinylcholine—Flushing—Melphalan—ovarian cancer	0.00484	0.0127	CcSEcCtD
Succinylcholine—Renal failure acute—Paclitaxel—ovarian cancer	0.00479	0.0126	CcSEcCtD
Succinylcholine—Arrhythmia—Melphalan—ovarian cancer	0.00466	0.0122	CcSEcCtD
Succinylcholine—Pulmonary oedema—Docetaxel—ovarian cancer	0.0046	0.012	CcSEcCtD
Succinylcholine—Flushing—Vinorelbine—ovarian cancer	0.00423	0.0111	CcSEcCtD
Succinylcholine—Cardiac arrest—Paclitaxel—ovarian cancer	0.00421	0.011	CcSEcCtD
Succinylcholine—Arrhythmia—Vinorelbine—ovarian cancer	0.00407	0.0106	CcSEcCtD
Succinylcholine—Myalgia—Topotecan—ovarian cancer	0.00394	0.0103	CcSEcCtD
Succinylcholine—BCHE—lymph node—ovarian cancer	0.00388	0.00718	CbGeAlD
Succinylcholine—Myalgia—Melphalan—ovarian cancer	0.00386	0.0101	CcSEcCtD
Succinylcholine—Anaphylactic shock—Topotecan—ovarian cancer	0.00378	0.0099	CcSEcCtD
Succinylcholine—Anaphylactic shock—Melphalan—ovarian cancer	0.0037	0.00969	CcSEcCtD
Succinylcholine—Tachycardia—Melphalan—ovarian cancer	0.00361	0.00946	CcSEcCtD
Succinylcholine—Hypotension—Melphalan—ovarian cancer	0.00346	0.00906	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00344	0.00902	CcSEcCtD
Succinylcholine—Hyperkalaemia—Epirubicin—ovarian cancer	0.00343	0.00897	CcSEcCtD
Succinylcholine—Hypertension—Vinorelbine—ovarian cancer	0.00342	0.00896	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Epirubicin—ovarian cancer	0.00339	0.00886	CcSEcCtD
Succinylcholine—Urticaria—Chlorambucil—ovarian cancer	0.00337	0.00883	CcSEcCtD
Succinylcholine—Myalgia—Vinorelbine—ovarian cancer	0.00337	0.00883	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00337	0.00883	CcSEcCtD
Succinylcholine—Body temperature increased—Chlorambucil—ovarian cancer	0.00336	0.00879	CcSEcCtD
Succinylcholine—Renal failure—Paclitaxel—ovarian cancer	0.00335	0.00878	CcSEcCtD
Succinylcholine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00323	0.00847	CcSEcCtD
Succinylcholine—Bronchospasm—Docetaxel—ovarian cancer	0.00319	0.00835	CcSEcCtD
Succinylcholine—Hyperkalaemia—Doxorubicin—ovarian cancer	0.00317	0.0083	CcSEcCtD
Succinylcholine—Tachycardia—Vinorelbine—ovarian cancer	0.00316	0.00827	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.00313	0.0082	CcSEcCtD
Succinylcholine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00313	0.00819	CcSEcCtD
Succinylcholine—Bradycardia—Paclitaxel—ovarian cancer	0.00312	0.00816	CcSEcCtD
Succinylcholine—Pulmonary oedema—Epirubicin—ovarian cancer	0.0031	0.00812	CcSEcCtD
Succinylcholine—Hypertonia—Epirubicin—ovarian cancer	0.00306	0.008	CcSEcCtD
Succinylcholine—Hypotension—Vinorelbine—ovarian cancer	0.00302	0.00791	CcSEcCtD
Succinylcholine—Urticaria—Topotecan—ovarian cancer	0.003	0.00786	CcSEcCtD
Succinylcholine—Body temperature increased—Topotecan—ovarian cancer	0.00299	0.00783	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00295	0.00772	CcSEcCtD
Succinylcholine—Urticaria—Melphalan—ovarian cancer	0.00294	0.0077	CcSEcCtD
Succinylcholine—Pulmonary oedema—Doxorubicin—ovarian cancer	0.00287	0.00752	CcSEcCtD
Succinylcholine—Renal failure—Docetaxel—ovarian cancer	0.00284	0.00744	CcSEcCtD
Succinylcholine—Flushing—Paclitaxel—ovarian cancer	0.00284	0.00744	CcSEcCtD
Succinylcholine—Hypertonia—Doxorubicin—ovarian cancer	0.00283	0.0074	CcSEcCtD
Succinylcholine—Hypersensitivity—Topotecan—ovarian cancer	0.00279	0.00729	CcSEcCtD
Succinylcholine—Renal failure acute—Epirubicin—ovarian cancer	0.00274	0.00718	CcSEcCtD
Succinylcholine—Arrhythmia—Paclitaxel—ovarian cancer	0.00274	0.00716	CcSEcCtD
Succinylcholine—Hypersensitivity—Melphalan—ovarian cancer	0.00273	0.00714	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00261	0.00685	CcSEcCtD
Succinylcholine—Urticaria—Vinorelbine—ovarian cancer	0.00257	0.00673	CcSEcCtD
Succinylcholine—Body temperature increased—Vinorelbine—ovarian cancer	0.00256	0.00669	CcSEcCtD
Succinylcholine—Renal failure acute—Doxorubicin—ovarian cancer	0.00254	0.00664	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00242	0.00633	CcSEcCtD
Succinylcholine—Flushing—Docetaxel—ovarian cancer	0.00241	0.00631	CcSEcCtD
Succinylcholine—Cardiac arrest—Epirubicin—ovarian cancer	0.00241	0.0063	CcSEcCtD
Succinylcholine—Rash—Topotecan—ovarian cancer	0.00238	0.00624	CcSEcCtD
Succinylcholine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00238	0.00624	CcSEcCtD
Succinylcholine—Dermatitis—Topotecan—ovarian cancer	0.00238	0.00624	CcSEcCtD
Succinylcholine—Rash—Melphalan—ovarian cancer	0.00233	0.00611	CcSEcCtD
Succinylcholine—Dermatitis—Melphalan—ovarian cancer	0.00233	0.00611	CcSEcCtD
Succinylcholine—Arrhythmia—Docetaxel—ovarian cancer	0.00232	0.00607	CcSEcCtD
Succinylcholine—Hypertension—Paclitaxel—ovarian cancer	0.0023	0.00603	CcSEcCtD
Succinylcholine—Myalgia—Paclitaxel—ovarian cancer	0.00227	0.00594	CcSEcCtD
Succinylcholine—Cardiac arrest—Doxorubicin—ovarian cancer	0.00223	0.00583	CcSEcCtD
Succinylcholine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00218	0.0057	CcSEcCtD
Succinylcholine—Shock—Paclitaxel—ovarian cancer	0.00214	0.0056	CcSEcCtD
Succinylcholine—Tachycardia—Paclitaxel—ovarian cancer	0.00212	0.00556	CcSEcCtD
Succinylcholine—Rash—Vinorelbine—ovarian cancer	0.00204	0.00534	CcSEcCtD
Succinylcholine—Dermatitis—Vinorelbine—ovarian cancer	0.00204	0.00533	CcSEcCtD
Succinylcholine—Hypotension—Paclitaxel—ovarian cancer	0.00203	0.00532	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00198	0.00519	CcSEcCtD
Succinylcholine—Hypertension—Docetaxel—ovarian cancer	0.00195	0.00511	CcSEcCtD
Succinylcholine—Myalgia—Docetaxel—ovarian cancer	0.00192	0.00504	CcSEcCtD
Succinylcholine—Renal failure—Epirubicin—ovarian cancer	0.00192	0.00502	CcSEcCtD
Succinylcholine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00184	0.00483	CcSEcCtD
Succinylcholine—Shock—Docetaxel—ovarian cancer	0.00181	0.00475	CcSEcCtD
Succinylcholine—Tachycardia—Docetaxel—ovarian cancer	0.0018	0.00471	CcSEcCtD
Succinylcholine—Bradycardia—Epirubicin—ovarian cancer	0.00178	0.00467	CcSEcCtD
Succinylcholine—Renal failure—Doxorubicin—ovarian cancer	0.00177	0.00464	CcSEcCtD
Succinylcholine—Urticaria—Paclitaxel—ovarian cancer	0.00173	0.00453	CcSEcCtD
Succinylcholine—Hypotension—Docetaxel—ovarian cancer	0.00172	0.00451	CcSEcCtD
Succinylcholine—Body temperature increased—Paclitaxel—ovarian cancer	0.00172	0.0045	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00168	0.0044	CcSEcCtD
Succinylcholine—Bradycardia—Doxorubicin—ovarian cancer	0.00165	0.00432	CcSEcCtD
Succinylcholine—Flushing—Epirubicin—ovarian cancer	0.00162	0.00425	CcSEcCtD
Succinylcholine—Hypersensitivity—Paclitaxel—ovarian cancer	0.0016	0.0042	CcSEcCtD
Succinylcholine—Arrhythmia—Epirubicin—ovarian cancer	0.00156	0.00409	CcSEcCtD
Succinylcholine—Flushing—Doxorubicin—ovarian cancer	0.0015	0.00394	CcSEcCtD
Succinylcholine—Body temperature increased—Docetaxel—ovarian cancer	0.00146	0.00382	CcSEcCtD
Succinylcholine—Arrhythmia—Doxorubicin—ovarian cancer	0.00145	0.00379	CcSEcCtD
Succinylcholine—Rash—Paclitaxel—ovarian cancer	0.00137	0.00359	CcSEcCtD
Succinylcholine—Dermatitis—Paclitaxel—ovarian cancer	0.00137	0.00359	CcSEcCtD
Succinylcholine—Hypersensitivity—Docetaxel—ovarian cancer	0.00136	0.00356	CcSEcCtD
Succinylcholine—Hypertension—Epirubicin—ovarian cancer	0.00132	0.00345	CcSEcCtD
Succinylcholine—Myalgia—Epirubicin—ovarian cancer	0.0013	0.0034	CcSEcCtD
Succinylcholine—Anaphylactic shock—Epirubicin—ovarian cancer	0.00124	0.00326	CcSEcCtD
Succinylcholine—Shock—Epirubicin—ovarian cancer	0.00122	0.0032	CcSEcCtD
Succinylcholine—Hypertension—Doxorubicin—ovarian cancer	0.00122	0.00319	CcSEcCtD
Succinylcholine—Tachycardia—Epirubicin—ovarian cancer	0.00121	0.00318	CcSEcCtD
Succinylcholine—Myalgia—Doxorubicin—ovarian cancer	0.0012	0.00314	CcSEcCtD
Succinylcholine—Rash—Docetaxel—ovarian cancer	0.00116	0.00304	CcSEcCtD
Succinylcholine—Hypotension—Epirubicin—ovarian cancer	0.00116	0.00304	CcSEcCtD
Succinylcholine—Dermatitis—Docetaxel—ovarian cancer	0.00116	0.00304	CcSEcCtD
Succinylcholine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00115	0.00301	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00113	0.00297	CcSEcCtD
Succinylcholine—Shock—Doxorubicin—ovarian cancer	0.00113	0.00296	CcSEcCtD
Succinylcholine—Tachycardia—Doxorubicin—ovarian cancer	0.00112	0.00294	CcSEcCtD
Succinylcholine—Hypotension—Doxorubicin—ovarian cancer	0.00108	0.00282	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00105	0.00275	CcSEcCtD
Succinylcholine—Urticaria—Epirubicin—ovarian cancer	0.000988	0.00259	CcSEcCtD
Succinylcholine—Body temperature increased—Epirubicin—ovarian cancer	0.000983	0.00257	CcSEcCtD
Succinylcholine—Hypersensitivity—Epirubicin—ovarian cancer	0.000916	0.0024	CcSEcCtD
Succinylcholine—Urticaria—Doxorubicin—ovarian cancer	0.000914	0.00239	CcSEcCtD
Succinylcholine—Body temperature increased—Doxorubicin—ovarian cancer	0.00091	0.00238	CcSEcCtD
Succinylcholine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000848	0.00222	CcSEcCtD
Succinylcholine—Rash—Epirubicin—ovarian cancer	0.000784	0.00205	CcSEcCtD
Succinylcholine—Dermatitis—Epirubicin—ovarian cancer	0.000783	0.00205	CcSEcCtD
Succinylcholine—Rash—Doxorubicin—ovarian cancer	0.000726	0.0019	CcSEcCtD
Succinylcholine—Dermatitis—Doxorubicin—ovarian cancer	0.000725	0.0019	CcSEcCtD
Succinylcholine—CHRM2—Signaling Pathways—PPP1CC—ovarian cancer	6.6e-05	0.000851	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—MAPK1—ovarian cancer	6.55e-05	0.000844	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	6.54e-05	0.000843	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	6.52e-05	0.00084	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	6.3e-05	0.000812	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	6.28e-05	0.00081	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	6.22e-05	0.000802	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	6.22e-05	0.000802	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	6.22e-05	0.000802	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	6.2e-05	0.0008	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	6.2e-05	0.000799	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—IL6—ovarian cancer	6.1e-05	0.000786	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.05e-05	0.000779	CbGpPWpGaD
Succinylcholine—CHRM1—G alpha (q) signalling events—PIK3CA—ovarian cancer	6.04e-05	0.000778	CbGpPWpGaD
Succinylcholine—CHRM3—G alpha (q) signalling events—PIK3CA—ovarian cancer	6.02e-05	0.000776	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	5.88e-05	0.000758	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	5.86e-05	0.000755	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—FASN—ovarian cancer	5.67e-05	0.00073	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—SLC5A5—ovarian cancer	5.58e-05	0.000718	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—TP53—ovarian cancer	5.51e-05	0.000711	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	5.4e-05	0.000696	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—SLC2A1—ovarian cancer	5.38e-05	0.000694	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	5.38e-05	0.000694	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—YAP1—ovarian cancer	5.35e-05	0.000689	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.27e-05	0.000679	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of proteins—MMP2—ovarian cancer	5.27e-05	0.000679	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—HRAS—ovarian cancer	5.26e-05	0.000678	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CYP1B1—ovarian cancer	5.16e-05	0.000665	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HDAC6—ovarian cancer	5.07e-05	0.000653	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HDAC6—ovarian cancer	5.05e-05	0.000651	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—IL6—ovarian cancer	5.05e-05	0.00065	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HDAC6—ovarian cancer	5e-05	0.000645	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PPP2R1A—ovarian cancer	5e-05	0.000644	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	5e-05	0.000644	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PPP2R1A—ovarian cancer	4.98e-05	0.000642	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	4.98e-05	0.000642	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PPP2R1A—ovarian cancer	4.93e-05	0.000636	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—CXCL8—ovarian cancer	4.8e-05	0.000619	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—CXCL8—ovarian cancer	4.79e-05	0.000617	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	4.78e-05	0.000616	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	4.77e-05	0.000614	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—CXCL8—ovarian cancer	4.74e-05	0.000611	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PPP2R1A—ovarian cancer	4.58e-05	0.00059	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.56e-05	0.000587	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—YAP1—ovarian cancer	4.48e-05	0.000578	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—YAP1—ovarian cancer	4.47e-05	0.000576	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—YAP1—ovarian cancer	4.43e-05	0.00057	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—XIAP—ovarian cancer	4.39e-05	0.000566	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—XIAP—ovarian cancer	4.38e-05	0.000564	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of proteins—CXCL8—ovarian cancer	4.38e-05	0.000564	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—FASN—ovarian cancer	4.36e-05	0.000562	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—XIAP—ovarian cancer	4.34e-05	0.000559	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—SLC5A5—ovarian cancer	4.29e-05	0.000552	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SMARCA4—ovarian cancer	4.28e-05	0.000552	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SMARCA4—ovarian cancer	4.27e-05	0.00055	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ABCB1—ovarian cancer	4.25e-05	0.000548	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SMARCA4—ovarian cancer	4.23e-05	0.000545	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EREG—ovarian cancer	4.18e-05	0.000539	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—TYMS—ovarian cancer	4.17e-05	0.000538	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EREG—ovarian cancer	4.17e-05	0.000537	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—SLC2A1—ovarian cancer	4.14e-05	0.000534	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EREG—ovarian cancer	4.13e-05	0.000532	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of proteins—CTNNB1—ovarian cancer	4.04e-05	0.00052	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CYP1B1—ovarian cancer	3.97e-05	0.000512	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PGR—ovarian cancer	3.92e-05	0.000505	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PGR—ovarian cancer	3.9e-05	0.000503	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PGR—ovarian cancer	3.87e-05	0.000498	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CG—ovarian cancer	3.68e-05	0.000475	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CG—ovarian cancer	3.67e-05	0.000473	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PARP1—ovarian cancer	3.64e-05	0.000469	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CG—ovarian cancer	3.64e-05	0.000469	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PARP1—ovarian cancer	3.63e-05	0.000468	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PARP1—ovarian cancer	3.59e-05	0.000463	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPP2R1A—ovarian cancer	3.52e-05	0.000454	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6ST—ovarian cancer	3.48e-05	0.000449	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6ST—ovarian cancer	3.47e-05	0.000447	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6ST—ovarian cancer	3.44e-05	0.000443	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CAV1—ovarian cancer	3.36e-05	0.000434	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CG—ovarian cancer	3.35e-05	0.000431	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CG—ovarian cancer	3.34e-05	0.00043	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CG—ovarian cancer	3.3e-05	0.000426	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ABCB1—ovarian cancer	3.27e-05	0.000421	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CD—ovarian cancer	3.24e-05	0.000417	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CD—ovarian cancer	3.23e-05	0.000416	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.21e-05	0.000414	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—TYMS—ovarian cancer	3.21e-05	0.000414	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CD—ovarian cancer	3.2e-05	0.000412	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CG—ovarian cancer	3.06e-05	0.000395	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PPP2R1A—ovarian cancer	2.95e-05	0.000381	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PPP2R1A—ovarian cancer	2.94e-05	0.000379	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CD—ovarian cancer	2.94e-05	0.000379	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CD—ovarian cancer	2.93e-05	0.000378	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PPP2R1A—ovarian cancer	2.92e-05	0.000376	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CD—ovarian cancer	2.9e-05	0.000374	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CB—ovarian cancer	2.82e-05	0.000364	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CB—ovarian cancer	2.81e-05	0.000363	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CB—ovarian cancer	2.79e-05	0.000359	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CXCL8—ovarian cancer	2.71e-05	0.00035	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CXCL8—ovarian cancer	2.7e-05	0.000349	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CD—ovarian cancer	2.69e-05	0.000347	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CXCL8—ovarian cancer	2.68e-05	0.000345	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—IL2—ovarian cancer	2.59e-05	0.000334	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CAV1—ovarian cancer	2.59e-05	0.000333	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—IL2—ovarian cancer	2.58e-05	0.000333	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CB—ovarian cancer	2.56e-05	0.00033	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—IL2—ovarian cancer	2.56e-05	0.00033	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CB—ovarian cancer	2.56e-05	0.000329	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CB—ovarian cancer	2.53e-05	0.000326	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CXCL8—ovarian cancer	2.46e-05	0.000317	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CXCL8—ovarian cancer	2.46e-05	0.000316	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CXCL8—ovarian cancer	2.43e-05	0.000313	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CG—ovarian cancer	2.36e-05	0.000304	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL2—ovarian cancer	2.35e-05	0.000303	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CB—ovarian cancer	2.35e-05	0.000303	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL2—ovarian cancer	2.35e-05	0.000302	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TERT—ovarian cancer	2.35e-05	0.000302	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TERT—ovarian cancer	2.34e-05	0.000301	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL2—ovarian cancer	2.32e-05	0.0003	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TERT—ovarian cancer	2.32e-05	0.000298	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CAV1—ovarian cancer	2.17e-05	0.00028	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CAV1—ovarian cancer	2.16e-05	0.000279	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CAV1—ovarian cancer	2.14e-05	0.000276	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ESR1—ovarian cancer	2.09e-05	0.000269	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ESR1—ovarian cancer	2.08e-05	0.000269	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CD—ovarian cancer	2.07e-05	0.000267	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ESR1—ovarian cancer	2.06e-05	0.000266	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6ST—ovarian cancer	2.06e-05	0.000265	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6ST—ovarian cancer	2.05e-05	0.000264	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6ST—ovarian cancer	2.03e-05	0.000262	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTEN—ovarian cancer	2.03e-05	0.000261	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APC—ovarian cancer	1.98e-05	0.000255	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CG—ovarian cancer	1.98e-05	0.000255	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—NRAS—ovarian cancer	1.98e-05	0.000255	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APC—ovarian cancer	1.97e-05	0.000254	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CG—ovarian cancer	1.97e-05	0.000254	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—NRAS—ovarian cancer	1.97e-05	0.000254	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APC—ovarian cancer	1.95e-05	0.000251	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CG—ovarian cancer	1.95e-05	0.000251	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—NRAS—ovarian cancer	1.95e-05	0.000251	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—MAPK3—ovarian cancer	1.89e-05	0.000244	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—MAPK3—ovarian cancer	1.89e-05	0.000243	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—MAPK3—ovarian cancer	1.87e-05	0.000241	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CB—ovarian cancer	1.81e-05	0.000233	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—MAPK1—ovarian cancer	1.8e-05	0.000232	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—EGFR—ovarian cancer	1.8e-05	0.000232	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—MAPK1—ovarian cancer	1.8e-05	0.000231	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—EGFR—ovarian cancer	1.8e-05	0.000231	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—MAPK1—ovarian cancer	1.78e-05	0.000229	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—EGFR—ovarian cancer	1.78e-05	0.000229	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CD—ovarian cancer	1.74e-05	0.000224	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CD—ovarian cancer	1.73e-05	0.000223	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CA—ovarian cancer	1.72e-05	0.000222	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CA—ovarian cancer	1.72e-05	0.000221	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CD—ovarian cancer	1.72e-05	0.000221	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—KRAS—ovarian cancer	1.7e-05	0.000219	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CA—ovarian cancer	1.7e-05	0.000219	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—KRAS—ovarian cancer	1.7e-05	0.000219	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—KRAS—ovarian cancer	1.68e-05	0.000216	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CA—ovarian cancer	1.56e-05	0.000201	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTEN—ovarian cancer	1.56e-05	0.000201	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CA—ovarian cancer	1.56e-05	0.000201	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CA—ovarian cancer	1.54e-05	0.000199	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ERBB2—ovarian cancer	1.53e-05	0.000198	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ERBB2—ovarian cancer	1.53e-05	0.000197	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ERBB2—ovarian cancer	1.52e-05	0.000195	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MTOR—ovarian cancer	1.51e-05	0.000195	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CB—ovarian cancer	1.51e-05	0.000195	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MTOR—ovarian cancer	1.51e-05	0.000195	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CB—ovarian cancer	1.51e-05	0.000195	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MTOR—ovarian cancer	1.5e-05	0.000193	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CB—ovarian cancer	1.5e-05	0.000193	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CXCL8—ovarian cancer	1.46e-05	0.000188	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CXCL8—ovarian cancer	1.45e-05	0.000187	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HRAS—ovarian cancer	1.45e-05	0.000186	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HRAS—ovarian cancer	1.44e-05	0.000186	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CXCL8—ovarian cancer	1.44e-05	0.000185	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CA—ovarian cancer	1.43e-05	0.000184	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HRAS—ovarian cancer	1.43e-05	0.000184	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDKN1B—ovarian cancer	1.42e-05	0.000183	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDKN1B—ovarian cancer	1.42e-05	0.000183	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—ovarian cancer	1.41e-05	0.000181	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDKN1B—ovarian cancer	1.4e-05	0.000181	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—ovarian cancer	1.4e-05	0.000181	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CASP3—ovarian cancer	1.39e-05	0.00018	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL2—ovarian cancer	1.39e-05	0.000179	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CASP3—ovarian cancer	1.39e-05	0.000179	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—ovarian cancer	1.39e-05	0.000179	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL2—ovarian cancer	1.39e-05	0.000179	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6—ovarian cancer	1.38e-05	0.000178	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6—ovarian cancer	1.38e-05	0.000178	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CASP3—ovarian cancer	1.38e-05	0.000177	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL2—ovarian cancer	1.37e-05	0.000177	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6—ovarian cancer	1.37e-05	0.000176	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCND1—ovarian cancer	1.36e-05	0.000175	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCND1—ovarian cancer	1.35e-05	0.000174	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CTNNB1—ovarian cancer	1.34e-05	0.000173	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCND1—ovarian cancer	1.34e-05	0.000172	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CTNNB1—ovarian cancer	1.34e-05	0.000172	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CTNNB1—ovarian cancer	1.33e-05	0.000171	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP9—ovarian cancer	1.32e-05	0.00017	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP9—ovarian cancer	1.31e-05	0.000169	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTEN—ovarian cancer	1.31e-05	0.000169	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTEN—ovarian cancer	1.3e-05	0.000168	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP9—ovarian cancer	1.3e-05	0.000167	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTEN—ovarian cancer	1.29e-05	0.000166	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	1.28e-05	0.000165	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—ovarian cancer	1.27e-05	0.000164	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	1.26e-05	0.000162	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	1.18e-05	0.000152	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VEGFA—ovarian cancer	1.18e-05	0.000152	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STAT3—ovarian cancer	1.17e-05	0.000151	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—ovarian cancer	1.17e-05	0.000151	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NRAS—ovarian cancer	1.17e-05	0.00015	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	1.17e-05	0.00015	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STAT3—ovarian cancer	1.17e-05	0.00015	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NRAS—ovarian cancer	1.16e-05	0.00015	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STAT3—ovarian cancer	1.16e-05	0.000149	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NRAS—ovarian cancer	1.15e-05	0.000149	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	1.12e-05	0.000144	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK3—ovarian cancer	1.11e-05	0.000144	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	1.1e-05	0.000142	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CA—ovarian cancer	1.1e-05	0.000142	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MYC—ovarian cancer	1.09e-05	0.00014	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MYC—ovarian cancer	1.08e-05	0.00014	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MYC—ovarian cancer	1.07e-05	0.000138	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	1.06e-05	0.000137	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EGFR—ovarian cancer	1.06e-05	0.000137	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK1—ovarian cancer	1.06e-05	0.000137	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EGFR—ovarian cancer	1.06e-05	0.000137	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	1.05e-05	0.000135	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EGFR—ovarian cancer	1.05e-05	0.000135	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KRAS—ovarian cancer	1e-05	0.000129	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KRAS—ovarian cancer	1e-05	0.000129	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KRAS—ovarian cancer	9.92e-06	0.000128	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	9.23e-06	0.000119	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CA—ovarian cancer	9.2e-06	0.000119	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	9.11e-06	0.000117	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—ovarian cancer	8.99e-06	0.000116	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TP53—ovarian cancer	8.93e-06	0.000115	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TP53—ovarian cancer	8.9e-06	0.000115	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TP53—ovarian cancer	8.82e-06	0.000114	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HRAS—ovarian cancer	8.54e-06	0.00011	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HRAS—ovarian cancer	8.51e-06	0.00011	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HRAS—ovarian cancer	8.43e-06	0.000109	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6—ovarian cancer	8.18e-06	0.000105	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6—ovarian cancer	8.15e-06	0.000105	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6—ovarian cancer	8.07e-06	0.000104	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—ovarian cancer	7.54e-06	9.72e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—ovarian cancer	7.52e-06	9.69e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—ovarian cancer	7.45e-06	9.59e-05	CbGpPWpGaD
